STUB1 and Parkinson disease: Irrespective, the possibility that CHIP targets tyrosine hydroxylase for degradation precludes it as a possible therapeutic intervention for PD since TH is a rate-limiting enzyme in the conversion of the amino acid tyrosine to the neurotransmitter dopamine [16], which is depleted in PD.